UBS Group’s Magellan Health Services MGLN Stock Holding History
Bought
Maintained
Sold
UBS Group's MGLN Position: Q1 2022 in Review
UBS Group sold out of Magellan Health Services (MGLN) in Q1 2022, closing a stake of 365,865 shares — an estimated $34.8M sold.
UBS Group first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $34.9M in Q3 2021. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- UBS Group reported no remaining Magellan Health Services position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 365,865 Magellan Health Services shares in Q1 2022, an estimated $34.8M.
- UBS Group first reported a position in Magellan Health Services in Q2 2013 and held it in 35 quarters.
- UBS Group's Magellan Health Services position peaked at $34.9M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Magellan Health Services as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.